Showing 16,581 - 16,600 results of 132,736 for search '(( a e decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.02s Refine Results
  1. 16581
  2. 16582
  3. 16583
  4. 16584

    Illustration showing the development of the two clusters of Pth4:eGFP neurons in control (A-D) and ablated larvae (E-H) from 1 to 7 dpf. by Paula Suarez-Bregua (4518343)

    Published 2017
    “…<p>After first and second round of ablation, 1 and 2 (at 1 and 2 dpf, respectively) the eGFP-expressing cells are totally eliminated (E and F); at 3 dpf and 7 dpf a low number of Pth4:eGFP-expressing neurons recover (G-H), but there remains significantly decreased <i>pth4</i> gene expression (***<i>p</i>< 0.001) in 7 dpf ablated larvae (I). …”
  5. 16585
  6. 16586

    Normalized diatom species abundance for all species (A) and mean Fisher Information (B) for Foy Lake. by Trisha L. Spanbauer (639221)

    Published 2014
    “…At ∼4.5 ka species evenness decreases, and the system begins a ∼2 kyr gradual decrease in mean FI. …”
  7. 16587
  8. 16588

    DataSheet1_Maternal vgll4a regulates zebrafish epiboly through Yap1 activity.PDF by Carlos Camacho-Macorra (11594935)

    Published 2024
    “…Taking these results together, we propose that maternal vgll4a acts at epiboly initiation upstream of yap1 and the E-cadherin/β-catenin adhesion complex, contributing to a proper balance between tissue tension/cohesion and contractility, thereby promoting a timely epiboly progression.…”
  9. 16589
  10. 16590
  11. 16591
  12. 16592

    Image_2_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.pdf by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  13. 16593

    Table_1_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  14. 16594

    Table_2_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  15. 16595

    Table_3_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.xlsx by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  16. 16596

    Image_1_Monocyte HLA-DR Assessment by a Novel Point-of-Care Device Is Feasible for Early Identification of ICU Patients With Complicated Courses—A Proof-of-Principle Study.pdf by Sandra Tamulyte (5421065)

    Published 2019
    “…</p><p>Results: Depending on the HLA-DR threshold applied for stratification (≤8,000/≤5,000/≤2,000 molecules/cell), a large group of patients (85.5/68.2/40.0%) already presented with a robust decrease of HLA-DR on admission, independent of the cause for critical illness. …”
  17. 16597
  18. 16598
  19. 16599
  20. 16600